 treatment experimental Pneumocystis carinii pneumonia oral nitrofuran derivatives broad-spectrum antimicrobial properties clinical use activity Pneumocystis carinii immunosuppressed rat model carinii pneumonia Furazolidone slight activity prophylactic agent effective therapy pneumocystosis median histologic score organism count cysts lung controls cysts lung furazolidone-treated groups results good standard drug trimethoprim-sulfamethoxazole cysts lung Nitrofurantoin little carinii activity different doses drug preparations high doses furazolidone toxic effects rats investigation drug treatment pneumocystosis humans many nitrofurans exploration class compounds helpful new carinii agents structure-activity relationships